Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Outcomes of SARS-CoV-2 Omicron infection in residents of Long-Term Care

Maria Krutikov, View ORCID ProfileOliver Stirrup, Hadjer Nacer-Laidi, Borscha Azmi, Chris Fuller, View ORCID ProfileGokhan Tut, Tom Palmer, Madhumita Shrotri, Aidan Irwin-Singer, Verity Baynton, The COVID-19 Genomics UK (COG-UK) consortium, Andrew Hayward, Paul Moss, Andrew Copas, View ORCID ProfileLaura Shallcross
doi: https://doi.org/10.1101/2022.01.21.22269605
Maria Krutikov
1Institute of Health Informatics, University College London UK
MRCP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliver Stirrup
2Institute for Global Health, University College London UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Oliver Stirrup
Hadjer Nacer-Laidi
1Institute of Health Informatics, University College London UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Borscha Azmi
1Institute of Health Informatics, University College London UK
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chris Fuller
1Institute of Health Informatics, University College London UK
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gokhan Tut
3Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gokhan Tut
Tom Palmer
2Institute for Global Health, University College London UK
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Madhumita Shrotri
1Institute of Health Informatics, University College London UK
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aidan Irwin-Singer
5Department of Health & Social Care, UK
MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Verity Baynton
5Department of Health & Social Care, UK
MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Hayward
4UCL Institute of Epidemiology & Health Care, UK
6Health Data Research UK
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Moss
3Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Copas
2Institute for Global Health, University College London UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Shallcross
1Institute of Health Informatics, University College London UK
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Laura Shallcross
  • For correspondence: l.shallcross@ucl.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Recently there has been a rapid, global increase in SARS-CoV-2 infections associated with the Omicron variant (B.1.1.529). Although severity of Omicron cases may be reduced, the scale of infection suggests hospital admissions and deaths may be substantial. Definitive conclusions about disease severity require evidence from populations with the greatest risk of severe outcomes, such as residents of Long-Term Care Facilities (LTCFs).

Methods We used a cohort study to compare the risk of hospital admission or death in LTCF residents in England who had tested positive for SARS-CoV-2 in the period shortly before Omicron emerged (Delta dominant) and the Omicron-dominant period, adjusting for age, sex, vaccine type, and booster vaccination. Variants were confirmed by sequencing or spike-gene status in a subset.

Results Risk of hospital admission was markedly lower in 398 residents infected in the pre-Omicron period (10.8% hospitalised, 95% CI: 8.13-14.29) compared to 1241 residents infected in the Omicron-period (4.01% hospitalised, 95% CI: 2.87-5.59, adjusted Hazard Ratio 0.50, 95% CI: 0.29-0.87, p=0.014); findings were similar in residents with confirmed variant. No residents with previous infection were hospitalised in either period. Mortality was lower in the Omicron versus the pre-Omicron period, (p<0.0001).

Conclusions Risk of severe outcomes in LTCF residents with the SARS-CoV-2 Omicron variant was substantially lower than that seen for previous variants. This suggests the current wave of Omicron infections is unlikely to lead to a major surge in severe disease in LTCF populations with high levels of vaccine coverage and/or natural immunity.

Trial Registration Number ISRCTN 14447421

Competing Interest Statement

LS and TP report grants from the Department of Health and Social Care during the conduct of the study and LS is a member of the Social Care Working Group, which reports to the Scientific Advisory Group for Emergencies. AIS and VB are employed by the Department of Health and Social Care who funded the study. AH reports funding from the Covid Core Studies Programme and is a member of the New and Emerging Respiratory Virus Threats Advisory Group at the Department of Health and Environmental Modelling Group of the Scientific Advisory Group for Emergencies. All other authors declare no competing interests.

Clinical Protocols

https://wellcomeopenresearch.org/articles/5-232

Funding Statement

This work is independent research funded by the Department of Health and Social Care (COVID-19 surveillance studies). MK is funded by a Wellcome Trust Clinical PhD Fellowship (222907/Z/21/Z). LS is funded by a National Institute for Health Research Clinician Scientist Award (CS-2016-007). AH is supported by Health Data Research UK (LOND1), which is funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, Department of Health and Social Care (England), Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (Northern Ireland), British Heart Foundation, and Wellcome Trust. COG-UK is supported by funding from the Medical Research Council (MRC) part of UK Research & Innovation (UKRI), the National Institute of Health Research (NIHR) [grant code: MC_PC_19027], and Genome Research Limited, operating as the Wellcome Sanger Institute. The views expressed in this publication are those of the authors and not necessarily those of the NHS, Public Health England, or the Department of Health and Social Care.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Research ethical approval for the study was granted by the South Central Hampshire B NHS REC ref: 20/SC/0238

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • https://www.cogconsortium.uk/ (COG-UK Consortium)

  • * Full list of consortium names and affiliations are in the appendix

Data Availability

De-identified test results and limited meta-data will be made available for use by researchers in future studies, subject to appropriate research ethical approvals, once the VIVALDI study cohort has been finalised

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted January 23, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Outcomes of SARS-CoV-2 Omicron infection in residents of Long-Term Care
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Outcomes of SARS-CoV-2 Omicron infection in residents of Long-Term Care
Maria Krutikov, Oliver Stirrup, Hadjer Nacer-Laidi, Borscha Azmi, Chris Fuller, Gokhan Tut, Tom Palmer, Madhumita Shrotri, Aidan Irwin-Singer, Verity Baynton, The COVID-19 Genomics UK (COG-UK) consortium, Andrew Hayward, Paul Moss, Andrew Copas, Laura Shallcross
medRxiv 2022.01.21.22269605; doi: https://doi.org/10.1101/2022.01.21.22269605
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Outcomes of SARS-CoV-2 Omicron infection in residents of Long-Term Care
Maria Krutikov, Oliver Stirrup, Hadjer Nacer-Laidi, Borscha Azmi, Chris Fuller, Gokhan Tut, Tom Palmer, Madhumita Shrotri, Aidan Irwin-Singer, Verity Baynton, The COVID-19 Genomics UK (COG-UK) consortium, Andrew Hayward, Paul Moss, Andrew Copas, Laura Shallcross
medRxiv 2022.01.21.22269605; doi: https://doi.org/10.1101/2022.01.21.22269605

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (135)
  • Cardiovascular Medicine (1749)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (654)
  • Epidemiology (10785)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2935)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1919)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12501)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (322)
  • Neurology (2785)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (556)
  • Occupational and Environmental Health (597)
  • Oncology (1458)
  • Ophthalmology (441)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (334)
  • Psychiatry and Clinical Psychology (2633)
  • Public and Global Health (5342)
  • Radiology and Imaging (1004)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (724)
  • Rheumatology (329)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)